Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Illuminating Glial Dysfunction in Alzheimer's Disease With Optical Coherence Tomography

NCT06023446 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT06023446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06023446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Illuminating Glial Dysfunction in Alzheimer's Disease With Optical Coherence Tomography
Lead sponsor
University of California, Davis
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 29, 2023
Completion date
February 28, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, mild cognitive impairment